ATA27585A - Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate - Google Patents

Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate

Info

Publication number
ATA27585A
ATA27585A AT85275A AT27585A ATA27585A AT A27585 A ATA27585 A AT A27585A AT 85275 A AT85275 A AT 85275A AT 27585 A AT27585 A AT 27585A AT A27585 A ATA27585 A AT A27585A
Authority
AT
Austria
Prior art keywords
pyridine derivatives
producing new
substituted furo
furo
substituted
Prior art date
Application number
AT85275A
Other languages
English (en)
Other versions
AT391700B (de
Inventor
Andre Esanu
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of ATA27585A publication Critical patent/ATA27585A/de
Application granted granted Critical
Publication of AT391700B publication Critical patent/AT391700B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
AT0027585A 1984-02-02 1985-01-31 Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate AT391700B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848402740A GB8402740D0 (en) 1984-02-02 1984-02-02 Furo-(3 4-c)-pyridine derivatives

Publications (2)

Publication Number Publication Date
ATA27585A true ATA27585A (de) 1990-05-15
AT391700B AT391700B (de) 1990-11-12

Family

ID=10555953

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0027585A AT391700B (de) 1984-02-02 1985-01-31 Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate

Country Status (24)

Country Link
US (1) US4581362A (de)
JP (1) JPS60181088A (de)
AT (1) AT391700B (de)
BE (1) BE901545A (de)
CA (1) CA1300148C (de)
CH (1) CH663023A5 (de)
DE (1) DE3503435A1 (de)
DK (1) DK158951C (de)
DZ (1) DZ743A1 (de)
ES (1) ES8607308A1 (de)
FI (1) FI82051C (de)
FR (2) FR2559152B1 (de)
GB (1) GB8402740D0 (de)
HK (1) HK92587A (de)
IE (1) IE58229B1 (de)
IT (1) IT1200587B (de)
LU (1) LU85744A1 (de)
MA (1) MA20342A1 (de)
NL (1) NL8500241A (de)
NO (1) NO160369C (de)
OA (1) OA07947A (de)
PT (1) PT79913B (de)
SE (2) SE460903B (de)
ZA (1) ZA85508B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
JPH054664A (ja) * 1991-06-21 1993-01-14 Yoozuri:Kk 運搬等用の包装体及び包装方法
WO2013102145A1 (en) 2011-12-28 2013-07-04 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
HUE035069T2 (en) 2011-12-28 2018-05-02 Global Blood Therapeutics Inc Substituted benzaldehyde compounds and their use to increase tissue oxygenation
CA2903022C (en) 2013-03-15 2021-11-09 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
KR20150132146A (ko) 2013-03-15 2015-11-25 글로벌 블러드 테라퓨틱스, 인크. 헤모글로빈 조정을 위한 화합물 및 이의 용도
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
PE20161035A1 (es) 2013-03-15 2016-11-13 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
JP6809681B2 (ja) 2014-02-07 2021-01-06 グローバル ブラッド セラピューティクス インコーポレイテッド 2−ヒドロキシ−6−((2−(1−イソプロピル−1h−ピラゾール−5−イル)ピリジン−3−イル)メトキシ)ベンズアルデヒドの遊離塩基の結晶多形
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之劑量方案
TWI663160B (zh) 2016-05-12 2019-06-21 全球血液治療公司 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (de) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulatoren von hämoglobin zur behandlung von sichelzellenanämie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786269B (en) * 1977-11-25 1979-10-31 Scras New pyridine derivative,its preparation and use
IN156817B (de) * 1981-02-10 1985-11-09 Scras
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives

Also Published As

Publication number Publication date
HK92587A (en) 1987-12-11
DK45585A (da) 1985-08-03
CH663023A5 (fr) 1987-11-13
OA07947A (fr) 1987-01-31
PT79913A (en) 1985-03-01
FI850275A0 (fi) 1985-01-22
SE8500460D0 (sv) 1985-02-01
NO850399L (no) 1985-08-05
DK45585D0 (da) 1985-02-01
IT8519327A0 (it) 1985-02-01
MA20342A1 (fr) 1985-10-01
GB8402740D0 (en) 1984-03-07
DK158951C (da) 1990-12-31
JPH0240069B2 (de) 1990-09-10
FR2559152A1 (fr) 1985-08-09
SE460903B (sv) 1989-12-04
PT79913B (en) 1986-11-10
DZ743A1 (fr) 2004-09-13
NO160369C (no) 1989-04-12
FI82051C (fi) 1991-01-10
ZA85508B (en) 1985-11-27
LU85744A1 (fr) 1985-07-24
SE8500460L (sv) 1985-08-03
FI82051B (fi) 1990-09-28
DE3503435A1 (de) 1985-08-08
NL8500241A (nl) 1985-09-02
IE850241L (en) 1985-08-02
FR2559062B1 (fr) 1987-05-22
FR2559062A1 (fr) 1985-08-09
ES540080A0 (es) 1986-05-16
DE3503435C2 (de) 1991-11-07
IT1200587B (it) 1989-01-27
US4581362A (en) 1986-04-08
AT391700B (de) 1990-11-12
FR2559152B1 (fr) 1987-05-22
ES8607308A1 (es) 1986-05-16
FI850275L (fi) 1985-08-03
CA1300148C (en) 1992-05-05
BE901545A (fr) 1985-07-22
JPS60181088A (ja) 1985-09-14
DK158951B (da) 1990-08-06
IE58229B1 (en) 1993-08-11
NO160369B (no) 1989-01-02

Similar Documents

Publication Publication Date Title
ATA27585A (de) Verfahren zur herstellung neuer 6-substituierter furo-(3,4-c)-pyridinderivate
ATA71183A (de) Verfahren zur herstellung neuer 3-keto-delta 4,9,19-norsteroid-derivate
ATA364384A (de) Verfahren zur herstellung neuer 6-vinyl-furo(3,4-c)-pyridinderivate
ATA112186A (de) Verfahren zur herstellung neuer imidazo(4,5-b)chinolinderivate
ATA365584A (de) Verfahren zur herstellung von 7-carboxymethoxyfuro-(3,4-c)-pyridinderivaten
AT382381B (de) Verfahren zur herstellung neuer grenzfl|chenaktiver kohlenhydrat-derivate
ATA165685A (de) Verfahren zur herstellung neuer 1,3-oxazolidin-2- derivate
AT379144B (de) Verfahren zur herstellung neuer 4,5-ungesaettigter 16-hydroxyprostansaeurederivate
DE3575128D1 (de) Verfahren zur herstellung von 4-acetoxy-3-hydroxyethylazetizin-2-on derivaten.
ATA337185A (de) Verfahren zur herstellung neuer flavolignanderivate
ATA124285A (de) Verfahren zur herstellung neuer iminothiazolidinderivate
ATA310385A (de) Verfahren zur herstellung neuer 6-phenaethylaminoalkyl-7-hydroxy-furo-(3,4-c)pyridinderivate
ATA218185A (de) Verfahren zur herstellung von neuen 6-substituierten mitomycinderivaten
ATA332984A (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
ATA305785A (de) Verfahren zur herstellung neuer 4h-dioxino-(4,5-c)-pyridinderivate
ATA335685A (de) Verfahren zur herstellung neuer thienopyridinderivate
ATA444982A (de) Verfahren zur herstellung neuer bisindolalkaloidderivate
ATA260285A (de) Verfahren zur herstellung neuer 6-aminomethyl-furo-(3,4-c)-pyridinderivate
ATA371584A (de) Verfahren zur herstellung neuer cephalosporanderivate
ATA105085A (de) Verfahren zur herstellung neuer s-triazolo (1,5-a) pyrimidine
AT381490B (de) Verfahren zur herstellung neuer 3,3-dialkylund 3,3-alkylen-indolinderivate
AT375077B (de) Verfahren zur herstellung neuer 4-phenyl-4,5,6,7tetrahydropyrrolo(2,3-c)pyridine
ATA323986A (de) Verfahren zur herstellung neuer 4-h-benzo(4,5)-cyclohepta(1,2-b)thiophenderivat
AT387576B (de) Verfahren zur herstellung neuer 1,3-oxazino(4,3-a)isochinolin-derivate
DE3582398D1 (de) Verfahren zur herstellung von substituierten pyridinen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee